financing

News

SonoThera's $125m Series B heads recent biofinancings

Our latest roundup of financings in the biotech sector includes impressive rounds for SonoThera, Ethyreal, CeQur, and City Therapeutics.

News

Cancer biotech Parabilis books record IPO, raising $670m

Parabilis has broken the IPO record set by Kailera in April, packing its coffers as it starts an ambitious trial programme for lead drug zolucatetide.

News

Parabilis prices IPO at an ambitious $475 million

Parabilis has set the terms of its IPO, seeking to raise a hefty $475m for phase 3 trials of its lead drug for desmoid tumours.

News

Analogue alarm clock with three piles of gold coins and plant shoot growing from them

NewLimit raises $435m for liver trials, and other financings

Longevity biotech NewLimit's $435m Series C heads this week's round-up of biotech venture capital financings.

News

GHO, CBC merge to create largest healthcare investment firm

Two top healthcare investors – UK-based GHO and CBC Group of Singapore – have announced a merger to create a massive player in the category.

News

Isomorphic raises $2.1bn for AI drug hunt

Isomorphic Labs has added to the lustre attached to its AI-powered drug discovery engine by raising an eye-watering $2.1 billion in a Series B round.

SonoThera's $125m Series B heads recent biofinancings

Cancer biotech Parabilis books record IPO, raising $670m

Parabilis prices IPO at an ambitious $475 million

NewLimit raises $435m for liver trials, and other financings

GHO, CBC merge to create largest healthcare investment firm

Isomorphic raises $2.1bn for AI drug hunt

CHMP backs Novo's haemophilia A drug Frehemgo

Discover a new era of healthcare panel engagement: Grounded ...

financing

Editor's Picks